Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lumateperone in Bipolar Mania
NCT06462586Phase 3Completed
- Sponsor
- Intra-Cellular Therapies
- Start
- Jun 2024
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of lumateperone in bipolar I disorder, sponsored by Intra-Cellular Therapies. Started Jun 2024; status: completed.
02
Drugs
lumateperone
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT06462586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06462586.